Gene: ZNF134
Official Full Name: zinc finger protein 134provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription repressor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in negative regulation of transcription by RNA polymerase II; regulation of cytokine production; and regulation of immune system process. Predicted to be located in nucleus. Predicted to be active in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34581 | ZNF134 Knockout cell line (HeLa) | Human | ZNF134 | 1:3~1:6 | Negative | Online Inquiry |
KO34582 | ZNF134 Knockout cell line (HCT 116) | Human | ZNF134 | 1:2~1:4 | Negative | Online Inquiry |
KO34583 | ZNF134 Knockout cell line (HEK293) | Human | ZNF134 | 1:3~1:6 | Negative | Online Inquiry |
KO34584 | ZNF134 Knockout cell line (A549) | Human | ZNF134 | 1:3~1:4 | Negative | Online Inquiry |
ZNF134 Gene Knockout Cell Lines are genetically engineered cell lines that facilitate the functional analysis of the ZNF134 gene by creating a complete loss-of-function model. These knockout cell lines are invaluable tools in molecular biology, enabling researchers to investigate the biological roles of ZNF134 in various cellular processes. The ZNF134 gene, which encodes a zinc finger protein, is implicated in critical regulatory mechanisms, including transcriptional control and genomic stability. By knocking out this gene, researchers can observe the resultant phenotypic alterations and infer its contributions to cellular pathways.
The mechanism of action involves the use of CRISPR-Cas9 technology or similar gene-editing techniques, which target specific sequences within the ZNF134 gene, effectively disrupting its expression. This precise gene-editing capability offers researchers the opportunity to study the effects of ZNF134 deficiency in cell growth, differentiation, apoptosis, and response to stressors. By analyzing these knockout cell lines, insights into the gene's role in pathophysiological conditions, such as cancer and neurodegenerative diseases, can be gleaned.
Scientifically, ZNF134 knockout cell lines provide a model for understanding the molecular underpinnings of diseases associated with ZNF134 dysfunction, positioning them as critical components in both research labs and clinical settings. Unlike alternative gene disruption methods, such as RNA interference, knockout cell lines provide a stable and permanent alteration in gene expression, leading to consistent experimental results over time.
The advantages of ZNF134 knockout cell lines extend beyond their stability; they also allow for high-throughput screening applications and enable researchers to conduct complex experiments that elucidate gene interactions in disease contexts. Researchers and clinicians benefit from the robust insights provided by these models, enhancing the capacity for translational research and therapeutic developments.
Our company, with years of expertise in genetic engineering and cell line development, is committed to supplying high-quality products that empower scientific exploration. We understand the importance of reliable models in accelerating discoveries, and our ZNF134 Gene Knockout Cell Lines exemplify our dedication to supporting pioneering research initiatives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.